Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing
Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection
Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24